TP53 and head and neck squamous cell carcinoma: While previous studies of the mutational profile of HPV-negative HNSCC have shown prevalence rates of TP53 mutations of 53%-78% [39, 40], these studies included either smaller sample sizes or were based on less sensitive whole exome sequencing (WES) data.